Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-21
2006-02-21
Gerstl, Robert (Department: 1639)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S229000, C548S232000, C435S006120
Reexamination Certificate
active
07002020
ABSTRACT:
Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
REFERENCES:
patent: 6441005 (2002-08-01), Gordeev et al.
patent: 2002/0169191 (2002-11-01), Gordeev et al.
patent: 196 49 095 (1997-08-01), None
patent: 0 050 827 (1982-05-01), None
patent: 0 184 170 (1986-06-01), None
patent: 0 281 289 (1988-09-01), None
patent: 0 312 000 (1989-04-01), None
patent: 0 316 594 (1989-05-01), None
patent: 0 352 781 (1990-01-01), None
patent: 0 359 172 (1990-03-01), None
patent: 0 359 418 (1990-03-01), None
patent: 0 693 491 (1996-01-01), None
patent: 0 694 543 (1996-01-01), None
patent: 0 694 544 (1996-01-01), None
patent: 0 738 726 (1996-10-01), None
patent: 0 785 201 (1997-07-01), None
patent: 0 789 026 (1997-08-01), None
patent: 04-327580 (1992-11-01), None
patent: WO 86/00991 (1986-02-01), None
patent: WO 91/07409 (1991-05-01), None
patent: WO 93/09103 (1993-05-01), None
patent: WO 93/23384 (1993-11-01), None
patent: WO 95/07271 (1995-03-01), None
patent: WO 95/14684 (1995-06-01), None
patent: WO 96/13502 (1996-05-01), None
patent: WO 97/09328 (1997-03-01), None
patent: WO 97/10223 (1997-03-01), None
patent: WO 97/19039 (1997-05-01), None
patent: WO 97/19089 (1997-05-01), None
patent: WO 97/21708 (1997-06-01), None
patent: WO 97/27188 (1997-07-01), None
patent: WO 97/30981 (1997-08-01), None
patent: WO 97/30995 (1997-08-01), None
patent: WO 97/31917 (1997-09-01), None
patent: WO 98/01446 (1998-01-01), None
patent: WO 98/01447 (1998-01-01), None
Balkenhohl et al., (1996) “Combinatorial Synthesis of Small Organic Molecules,”Angewandte Chemie.International Edition, vol. 35, No. 20, pp. 2288-2237.
Buchstaller, H. (Apr. 2, 1998) “Solid Phase Synthesis of Oxazolidinones via a Novel Cyclisation/Cleavage Reations,”Tetrahedronvol. 54, No. 14, pp. 3465-3470.
Holte, P. et al., (Oct. 1, 1998). Solid-Phase Synthesis of 3,5-Disubstituted 1,3-Oxazolidin-2-ones by an Activation/Cyclo-elimination Process,Tetrahedron Letters,vol. 39, No. 40, pp. 7407-7410.
Alasandro, M., “Separation of diastereoisomers of DuP 105, a novel oxazolidinone antibacterial agent, by supercritical fluid chromatography on a Chiralcel OD column” (1996)J. Pharm. Biomed.14:807-814.
Albert et al., “Comparison of in vitro trichomonacidal properties of some nitrofurans employed in therapeutics” (1973)Ann. Pharm. Fr.31:57-62. (English translation abstract).
Augé et al., “Lithium trifluoromethanesulfonate-catalysed aminolysis of oxiranes” (1996)Tetrahedron Letters37:7715-7716.
Barbachyn et al., “Potent Water Soluble Prodrugs of the Oxazolidine Antibacterial Agent Eperezolid”, Poster F-23, 37thInterscience Conference on Antimicrobial Agents and Chemotherepy,Toronto, Canada, Sep. 28 to Oct. 1, 1997.
Barbachyn et al., “Synthesis and structure activity relationships of new tropone-substituted oxazolidinone antibacterial agents” (1995)Abstracts of the 35th ICAAC Session 130. Poster Oxazolidinones.p. 149. (Abstract F206).
Barbachyn et al., “Identification of new oxazolidinone antibacterial agents with potent in vivo antimycobacterial activity” (1995)Abstracts of the 35th ICAAC Session 130. Poster Oxazolidinones.p. 152. (Abstract F227).
Barbachyn et al., “Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity” (1996)J. Med. Chem.39:680-685.
Barry et al., “In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents” (1988)Antimicrob. Agents Chemother.32:150-152.
Bartel et al., “Synthesis and Antibacterial Activity of Novel Hteroaryl Oxazolidinone I: Pyridyl Oxazolidinones”, Poster F-017, 37thInterscience Conference on Antimicrobial Agents and Chemotherepy,Toronto, Canada, Sep. 28 to Oct. 1, 1997.
Bartel et al., “Synthesis and Antibacterial Activity of Novel Heteroaryl Oxazolidinones II: Pyridyl Oxazolidinones”, Poster F-018, 37thInterscience Conference on Antimicrobial Agents and Chemotherepy,Toronto, Canada, Sep. 28 to Oct. 1, 1997.
Bartel et al., “Synthesis and Antibacterial Activity of Novel Heteroaryl Oxazolidinones III: Pyridyl Oxazolidinones”, Poster F-019, 37thInterscience Conference on Antimicrobial Agents and Chemotherepy,Toronto, Canada, Sep. 28 to Oct. 1, 1997.
Batts et al., “U-100592, phase I, multiple-dose, randomized placebo-controlled, safety, tolerance and pharmacokinetics in healthy volunteers for 14.25 days using bulk drug in capsules” (1995)Abstracts of the 35th ICAAC Session 130. Poster. Oxazolidinones.p. 152. (Abstract F226).
Bostic et al., “Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multi-drug resistant enterococci” (1995)Abstracts of the 35th ICAAC Session 130. Poster. Oxazolidinones.p. 151. (abstract F219).
Brickner et al., “Synthesis of U-100592 and U-100766, two new oxazolidinone antibacterial agents in clinical trials for treatment of multiply resistant gram positive infections” (1995)Abstracts of the 35th ICAAC Session 130. Poster. Oxazolidinones.p. 149. (abstract F208).
Brickner et al., Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections (1996)J. Med. Chem.39:673-679.
Brickner et al., “Oxazolidinone antibacterial agents” (1996)Curr. Pharm. Des.2:175-194.
Brumfitt et al., “In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones” (1988)J. Antimicrob. Chemother.21:711-720.
Brumfitt et al., “Antibacterial oxazolidinones: In vitro activity of a new analogue, E3709” (1992)Diagn. Microbiol. Infect. Dis.15:621-625.
Bush et al., “Kinetic interactitons of tazobactam with β-lactamases from all major structural classes” (1993)Antimicrobial Agents and Chemotherapy37:851-858.
Canonne et al.. “Synthesis of Chiral 3-Substituted 2,4(1H,3H)-Quinazolinediones” (1993),Heterocycles,36:1305-1314.
Daly et al., “Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds” (1988)J. Antimicrob. Chemother.21:721-730.
Daub et al., “Isolation, cloning, and sequencing of thesalmonella typhimurium ddlAgene with purification and characterization of its product, D-alanine:D-alanine ligase (ADP forming)” (1989)Biochemisry27:3701-3708.
Dellaria et al., “Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement” (1987)J. Med. Chem.30:2137-2144.
Demyan et al., “The Oxazolidinone Linezolid Inhibits Translation Initiation in Bacteria”, Poster C-102, 37thInterscience Conference on Antimicrobial Agents and Chemotherepy,Toronto, Canada, Sep. 28 to Oct. 1, 1997.
Denis et al., “5-aryl-β,γ butenolide, a new class of antibacterial derived from the n-aryl oxazolidinone DUP 721” (1994)Bioorg.&Med. Chem. Lett.4:1925-1930.
de Parrodi et al., “Preparation of enantiomerically pure cis- and trans-N-(propionyl)hexahydrobenzoxazolidin-2-ones” (1997)Tetrahedron: Asymmetry8:1075-1082.
Ding et al., “Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation” (1993)J. Med. Chem.36:3606-3610.
Eliopoulos et al., “Activities of the new oxazolidinone antimicrobials against enterococci” (1995)Abstracts of the 35th ICAAC Se
Gordeev Mikhail F.
Luehr Gary W.
Patel Dinesh V.
Epperson Jon D.
Gerstl Robert
O'Brien Jonathan P.
Pharmacia & Upjohn Company
Yang Lucy X.
LandOfFree
Oxazolidinone combinatorial libraries, compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidinone combinatorial libraries, compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidinone combinatorial libraries, compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3628492